HopeStageGet research updates
HopeStage
hi@hopestage.com

Built by people with lived experience, between Sydney and Paris.

Back to all studies
CompletedNCT05314153

Effects Zulresso on Postpartum Psychosis

Official study title

Open Label Study of the Efficacy, Safety and Tolerability of Zulresso in the Treatment of Adult Women With Postpartum Psychosis

Medication studyAges 18–45United StatesSchizophrenia
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 45 years.

Listed locations
Chapel Hill, United StatesSee all locations and recruitment
Activities
Medication described in the protocol
Compensation
Payment and expense reimbursement have not been verified.
Study clarity

Study information

Study start dateStarted: February 23, 2022
Recruitment status
Completed
Enrollment listed in the registry
10
Sponsor
University of North Carolina, Chapel Hill
Sponsor type
University
Study type
Drug
Intervention type
Medication / drug
Study phase
EARLY Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
Locations
United States
Age range
From 18 Years to 45 Years
Official registry ID
NCT05314153

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Chapel Hill

Checked Official study record (opens in a new tab)
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of North Carolina, Chapel Hill, a university.

Did this study involve medication?

Yes. The study involved medication, including Brexanolone.

Who was this study for?

Listed age limits: 18 years to 45 years.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.